RMCM
BIIB icon

Reynders McVeigh Capital Management’s Biogen BIIB Stock Holding History

Reynders McVeigh Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,850
Closed -$667K – 226
2019
Q2 		$667K Sell
2,850
-12,771
-82% -$2.95M 0.07% 125
2019
Q1 		$3.69M Sell
15,621
-1,588
-9% -$500K 0.41% 48
2018
Q4 		$5.18M Sell
17,209
-1,275
-7% -$407K 0.69% 35
2018
Q3 		$6.53M Buy
18,484
+860
+5% +$296K 0.77% 34
2018
Q2 		$5.12M Buy
17,624
+3,077
+21% +$865K 0.65% 38
2018
Q1 		$3.98M Buy
14,547
+3,797
+35% +$1.18M 0.5% 40
2017
Q4 		$3.42M Buy
10,750
+6,075
+130% +$1.95M 0.45% 46
2017
Q3 		$1.46M Buy
4,675
+3,646
+354% +$1.08M 0.19% 82
2017
Q2 		$279K Buy
1,029
+20
+2% +$5.29K 0.04% 184
2017
Q1 		$276K Sell
1,009
-66
-6% -$18.7K 0.04% 187
2016
Q4 		$305K Sell
1,075
-13
-1% -$3.85K 0.04% 183
2016
Q3 		$341K Sell
1,088
-186
-15% -$55.1K 0.05% 168
2016
Q2 		$308K Buy
1,274
+107
+9% +$28.2K 0.04% 175
2016
Q1 		$304K Buy
1,167
+67
+6% +$17.7K 0.05% 182
2015
Q4 		$337K Hold
1,100
– – 0.06% 154
2015
Q3 		$321K Buy
1,100
+425
+63% +$140K 0.06% 163
2015
Q2 		$273K Buy
+675
New +$271K 0.04% 174

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Reynders McVeigh Capital Management's BIIB Position: Q3 2019 in Review

Reynders McVeigh Capital Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 2,850 shares — an estimated $667K sold.

Reynders McVeigh Capital Management first reported a position in BIIB in Q2 2015 and held it in 17 quarters. The position peaked at $6.53M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Reynders McVeigh Capital Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 2,850 Biogen shares in Q3 2019, an estimated $667K.
  • Reynders McVeigh Capital Management first reported a position in Biogen in Q2 2015 and held it in 17 quarters.
  • Reynders McVeigh Capital Management's Biogen position peaked at $6.53M in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.